HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yung-Ming Chen Selected Research

methionyl-aspartyl-phenylalaninamide (MAPN)

10/2022Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yung-Ming Chen Research Topics

Disease

17Chronic Renal Insufficiency
12/2021 - 12/2002
15Fibrosis (Cirrhosis)
01/2021 - 12/2002
14Proteinuria
01/2021 - 12/2002
13Acute Kidney Injury (Acute Renal Failure)
11/2022 - 01/2008
10Adenoma (Adenomas)
10/2022 - 07/2002
9Hyperaldosteronism (Conn Syndrome)
10/2022 - 08/2009
8Chronic Kidney Failure (Chronic Renal Failure)
02/2019 - 01/2011
8Inflammation (Inflammations)
09/2016 - 12/2002
8Glomerulonephritis
04/2015 - 12/2002
7Hypertension (High Blood Pressure)
12/2021 - 05/2006
7Necrosis
01/2019 - 12/2003
6Critical Illness (Critically Ill)
11/2022 - 12/2008
6Sepsis (Septicemia)
02/2022 - 01/2008
5Heart Failure
12/2021 - 09/2009
5Ureteral Obstruction
11/2021 - 12/2011
5Reperfusion Injury
01/2019 - 10/2006
3Hypoxia (Hypoxemia)
11/2021 - 01/2021
3Anemia
01/2021 - 02/2014
3Peritoneal Fibrosis
01/2020 - 05/2006
3Nephritis
04/2015 - 12/2003
3Diabetes Mellitus
07/2010 - 01/2008
2Neoplasms (Cancer)
10/2022 - 04/2014
2Kidney Diseases (Kidney Disease)
01/2022 - 01/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 12/2011
2Renal Insufficiency (Renal Failure)
01/2020 - 12/2014
2Cardiovascular Diseases (Cardiovascular Disease)
06/2014 - 01/2011
2Peritonitis
09/2009 - 06/2008
2Membranous Glomerulonephritis (Membranous Nephropathy)
03/2005 - 08/2004
2Nephrotic Syndrome (Syndrome, Nephrotic)
03/2005 - 08/2004
2Disease Progression
08/2004 - 12/2002
1Cardio-Renal Syndrome
02/2022
1Atrial Fibrillation
12/2021
1Essential Hypertension
12/2021

Drug/Important Bio-Agent (IBA)

11AldosteroneIBA
10/2022 - 07/2002
11Pentoxifylline (Trental)FDA LinkGeneric
12/2021 - 12/2002
10Proteins (Proteins, Gene)FDA Link
10/2021 - 12/2003
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022 - 12/2002
5Angiotensin Receptor AntagonistsIBA
01/2022 - 06/2008
5CreatinineIBA
10/2021 - 12/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015 - 12/2003
4ErythropoietinFDA Link
11/2021 - 02/2016
4Hemoglobins (Hemoglobin)IBA
02/2019 - 01/2012
4Messenger RNA (mRNA)IBA
04/2015 - 12/2003
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2010 - 06/2004
3Lactic Acid (Lactate)FDA LinkGeneric
02/2022 - 01/2008
3Angiopoietin-2IBA
12/2021 - 01/2013
3DiureticsIBA
12/2021 - 06/2008
34- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
11/2021 - 01/2013
3Cysteine-Rich Protein 61IBA
10/2021 - 01/2013
3Losartan (Cozaar)FDA LinkGeneric
09/2015 - 09/2008
3Transforming Growth Factors (Transforming Growth Factor)IBA
04/2015 - 06/2008
3Dialysis SolutionsIBA
12/2014 - 07/2010
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2014 - 02/2011
3CollagenIBA
06/2014 - 01/2009
3Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2009 - 04/2006
3Angiotensin IIIBA
05/2007 - 08/2004
2omega-Chloroacetophenone (Mace)IBA
12/2021 - 01/2020
2Uric Acid (Urate)IBA
12/2021 - 01/2011
2Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
11/2021 - 01/2021
2Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2021 - 05/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2020 - 07/2013
2Sodium Hypochlorite (Clorox)IBA
01/2020 - 12/2014
2ChemokinesIBA
01/2020 - 12/2003
2Angiopoietin-1IBA
01/2019 - 01/2013
2Serum AlbuminIBA
01/2015 - 01/2008
2Dopamine Receptors (Dopamine Receptor)IBA
04/2014 - 05/2007
2CytokinesIBA
01/2013 - 06/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013 - 02/2011
2ReninIBA
03/2012 - 09/2011
2Platelet-Derived Growth FactorIBA
12/2011 - 12/2003
2Phosphates (Orthophosphate)IBA
01/2011 - 05/2004
2Sevelamer (RenaGel)FDA Link
01/2011 - 09/2010
2calcium acetate (Phoslo)FDA LinkGeneric
01/2011 - 09/2010
2Glucose (Dextrose)FDA LinkGeneric
07/2010 - 01/2008
2Kallikreins (Kallikrein)IBA
06/2008 - 10/2006
2Tissue Kallikreins (Tissue Kallikrein)IBA
06/2008 - 10/2006
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2006 - 10/2004
2Interleukin-1beta (Interleukin 1 beta)IBA
05/2006 - 05/2004
2Dietary ProteinsIBA
03/2005 - 08/2004
2Phosphodiesterase InhibitorsIBA
03/2005 - 12/2002
1Biomarkers (Surrogate Marker)IBA
11/2022
1Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
10/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
10/2022
1methionyl-aspartyl-phenylalaninamide (MAPN)IBA
10/2022
1CholesterolIBA
12/2021
1C-Reactive ProteinIBA
12/2021
1Activin Receptors (Activin Receptor)IBA
11/2021
1roxadustatIBA
11/2021

Therapy/Procedure

11Therapeutics
11/2022 - 08/2004
10Renal Replacement Therapy (Therapies, Renal Replacement)
11/2022 - 01/2008
6Adrenalectomy
10/2022 - 10/2009
5Peritoneal Dialysis
01/2020 - 06/2010
4Renal Dialysis (Hemodialysis)
12/2017 - 09/2009
4Nephrectomy
06/2014 - 12/2002
3Extracorporeal Membrane Oxygenation
01/2012 - 12/2008
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2012 - 03/2004
2Aftercare (After-Treatment)
01/2020 - 10/2009
2Continuous Renal Replacement Therapy
04/2010 - 09/2009
2Total Parenteral Nutrition
09/2009 - 01/2008
1Length of Stay
10/2021